Los Angeles Capital Management LLC Invests $505,000 in Paragon 28, Inc. (NYSE:FNA)

Los Angeles Capital Management LLC bought a new stake in shares of Paragon 28, Inc. (NYSE:FNA - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 48,931 shares of the company's stock, valued at approximately $505,000. Los Angeles Capital Management LLC owned about 0.06% of Paragon 28 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. JPMorgan Chase & Co. boosted its position in shares of Paragon 28 by 2,141.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 784,878 shares of the company's stock valued at $5,243,000 after acquiring an additional 749,865 shares during the last quarter. Stonepine Capital Management LLC purchased a new position in shares of Paragon 28 in the 3rd quarter worth $766,000. GSA Capital Partners LLP bought a new stake in shares of Paragon 28 in the 3rd quarter worth about $386,000. Barclays PLC lifted its holdings in shares of Paragon 28 by 180.6% in the 3rd quarter. Barclays PLC now owns 84,812 shares of the company's stock valued at $567,000 after acquiring an additional 54,591 shares during the last quarter. Finally, Wellington Management Group LLP grew its position in Paragon 28 by 7.0% in the third quarter. Wellington Management Group LLP now owns 694,799 shares of the company's stock worth $4,641,000 after acquiring an additional 45,215 shares in the last quarter. 63.57% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several analysts recently weighed in on FNA shares. Stephens restated an "equal weight" rating and set a $13.00 price target (down previously from $14.00) on shares of Paragon 28 in a report on Thursday, January 30th. Canaccord Genuity Group set a $13.00 target price on Paragon 28 in a research report on Wednesday, January 29th. Needham & Company LLC restated a "hold" rating and issued a $13.00 price target on shares of Paragon 28 in a report on Wednesday, January 29th. Finally, William Blair lowered shares of Paragon 28 from an "outperform" rating to a "market perform" rating in a report on Wednesday, January 29th. Four equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $14.20.

Remove Ads

Paragon 28 Stock Up 0.1 %

NYSE:FNA traded up $0.02 during mid-day trading on Friday, reaching $13.05. The company's stock had a trading volume of 651,991 shares, compared to its average volume of 834,082. The firm has a market capitalization of $1.09 billion, a PE ratio of -17.63 and a beta of 1.54. Paragon 28, Inc. has a 1 year low of $4.65 and a 1 year high of $13.13. The company has a quick ratio of 1.60, a current ratio of 3.50 and a debt-to-equity ratio of 0.79. The stock has a fifty day moving average of $12.01 and a 200-day moving average of $9.30.

Insiders Place Their Bets

In other Paragon 28 news, major shareholder Mvm Partners, Llc sold 27,142 shares of the stock in a transaction dated Monday, January 27th. The stock was sold at an average price of $11.62, for a total value of $315,390.04. Following the completion of the sale, the insider now directly owns 10,313,841 shares in the company, valued at approximately $119,846,832.42. This trade represents a 0.26 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Over the last ninety days, insiders sold 831,689 shares of company stock worth $10,742,364. 15.32% of the stock is owned by corporate insiders.

Paragon 28 Company Profile

Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.